<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8508183</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1289</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr. Neurol.</journal-id>
<journal-title-group>
<journal-title>Pediatric neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0887-8994</issn>
<issn pub-type="epub">1873-5150</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30249355</article-id>
<article-id pub-id-type="pmc">6289746</article-id>
<article-id pub-id-type="doi">10.1016/j.pediatrneurol.2018.08.008</article-id>
<article-id pub-id-type="manuscript">NIHMS1503470</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Somatic mutation in pediatric neurological diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rodin</surname>
<given-names>Rachel E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walsh</surname>
<given-names>Christopher A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<aff id="A1"><label>1</label>Division of Genetics and Genomics, Manton Center for Orphan Disease, and Howard Hughes Medical Institute, Boston Children’s Hospital, Boston, MA, USA; Departments of Neurology and Pediatrics, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.</aff>
</contrib-group>
<author-notes>
<corresp id="CR1">Correspondence to: <email>christopher.walsh@childrens.harvard.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>16</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>11</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2019</year>
</pub-date>
<volume>87</volume>
<fpage>20</fpage>
<lpage>22</lpage>
<!--elocation-id from pubmed: 10.1016/j.pediatrneurol.2018.08.008-->
<abstract id="ABS1">
<p id="P1">Genetic variation contributes significantly to brain function and dysfunction, and studying the genetic factors responsible for neurological phenotypes is tremendously valuable for understanding brain development, physiology, and pathophysiology, as well as for advancements in disease diagnostics and therapeutics. Many genetic determinants of neurobiology are inherited from parents through the germline and are present in all cells of an individual, but others, known as somatic or mosaic mutations, may be acquired post-conception and are therefore present in only a subset of an individual’s cells. While the relationship between somatic mutation and cancer is clear, recent studies have also established a role for somatic mutations in several non-malignant neurological diseases of childhood, including cerebral cortical malformations and epilepsy disorders, autism spectrum disorder, and other neuropsychiatric diseases.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>